Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial. (Q46793947)
Jump to navigation
Jump to search
scientific article published in October 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial. |
scientific article published in October 2005 |
Statements
1 reference
Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial (English)
Scott McNitt
1 reference
Wojciech Zareba
2 references
James P Daubert
1 reference
Arthur J Moss
W Jackson Hall
Patricia Severski
John R Windle
Jennifer L Robinson
Ming Qi
Michael Cieciorka
Allan S Manalan
Scott McNitt
1 October 2005
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference